QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)
QQQ   354.50 (+0.38%)
AAPL   180.96 (+0.22%)
MSFT   326.79 (+0.47%)
META   264.95 (+0.14%)
GOOGL   122.23 (+0.07%)
AMZN   123.43 (-0.66%)
TSLA   244.40 (+4.06%)
NVDA   387.70 (+0.68%)
NIO   7.74 (-0.64%)
BABA   85.50 (-0.74%)
AMD   124.92 (+3.20%)
T   15.96 (-0.75%)
F   13.74 (+1.18%)
MU   65.43 (+0.17%)
CGC   0.68 (-1.45%)
GE   106.30 (+0.22%)
DIS   91.95 (-0.63%)
AMC   4.77 (+1.92%)
PFE   38.97 (-0.31%)
PYPL   63.49 (-1.17%)
NFLX   420.02 (+2.60%)

PetCo Management Getting it Right? Earnings Beat Says Yes

Key Points

  • Shares of PetCo are trading lower amid initially opposing viewpoints on first-quarter 2023 earnings results. As short-term traders pile in to bring volatility into the stock, long-term investors may be able to acquire cheaper shares. 
  • As PetCo gets through its 'growth stage', it is expected to see some unfavorable figures out of operations and free cash flow, offset by growth in the top line and market share. Management knows this and is delivering on what they should. 
  • Analysts expect a double-digit upside in the stock as the company posts increased market share and realistic paths to continued growth. Management guidance provides an anchor which investors can pull on for 2023 profitability. 
  • 5 stocks we like better than Chewy

Petco stock price

Analysts expected PetCo Health and Wellness NASDAQ: WOOF to deliver first-quarter 2023 earnings per share of $0.025. However, many are waking to a satisfying surprise, as the American pet outlet reports a 140% upside beat for $0.06 earnings per share. Today, as the company releases all the significant information points and performance metrics for the quarter, the stock price is overhauled by a trader's market since most are focusing on some of the past negatives rather than the future positives.

As a result of the participant majority of Wednesday morning, WOOF stock is trading lower by as much as 7.6%.

PetCo has been outperforming other names in the sector, such as Chewy NASDAQ: CHWY, by as much as 70.2% during the past twelve months, as the performance spread in both companies' charts suggested. However, there is a critical point to touch on for investors, as Chewy's price-to-earnings ratio stands at an obscene 274.9x, compared to PetCo's more realistic 29.9x.

What matters most is how this multiple will be affected and the subsequent stock price, based on management's 2023 full-year guidance provided in today's press release


Why PetCo Shares are Lower 

Earnings should be taken with a pinch of salt, as they are heavily focused on the short-term cycles and performance of a company, and even a terrible quarter could still represent a fantastic company to invest in in the big picture. Today, PetCo reported a net loss of $1.9 million, compared to net income of $24.7 million just a year prior. Subsequently, following this loss, earnings per share declined from $0.14 in 2022 to today's $0.06 to represent a more than 50% contraction in investor earnings power. 

Investors can take refuge in understanding that the net loss came primarily from increased interest expenses paid by the company, as 2022 saw the most aggressive rate hikes in the nation in more than a decade. PetCo paid $37.2 million in interest expenses, 89% higher than $19.6 million just a year prior.

Operationally, however, the company reports a comparable sales increase of 5.1% year-over-year, stacked at 10.2% on a two-year basis.

Moreover, management reports this quarter to be the 18th consecutive quarter posting comparable sales growth, this metric being a widely followed key performance indicator (KPI) for the retail industry; growth in this aspect alone should have been enough to cushion any other blow. 

Lastly, some may be leaning hard on free cash flow concerns, as it is the lifeblood of any business and investment. Reporting a negative free cash flow of $24.4 million is a reasonable concern for investors. However, it is an understandable position since the company is still within its "growth stage."

Companies going through these growth spurs have yet to be expected to spit out free cash flow. Instead, they are held up against their effectiveness at growing revenues and market share. Based on the critical metrics, and management guidance, some will find today's sell-off to be an exaggeration. 

What to Expect Moving Forward from PetCo

PetCo analyst rating points to a 23.5% upside from today's prices, reasonably bullish and similarly cautious regarding the seeming 'contraction' being experienced in the business. Within their earnings presentation, management points to further achievements accruing to the credibility of a growth company.

For example, digital sales within the industry grew at a double-digit clip year-over-year, with continued growth in repeat delivery and digital pharmacy products. In addition, the number of pets veterinarians saw increased by 20% annually as the business added 375 veterinarians to its ecosystem. These expansionary measures point to further monetization opportunities for the company at the expense of the expected negative cash flows as management focuses on growth investing.

Two factors are what can spark future revenue growth, market share, and monetization, which can result in richer price-to-sales multiples in the business. First, revenue growth, with more recurring than discretionary revenue, is the more desired outcome since it will bring less volatility to the bottom line.

Second, PetCo's loyalty and membership programs brought over 100,000 new customers to Vital Care Premier, finishing the quarter with 580,000. These active customers' monthly membership fees accrue over $1 billion annually. They are expected to keep growing at high single-digits and retain their recurring nature. 

As management expects to finish 2023 with net sales between $6.15 billion and $6.275 billion, markets will see a growth rate of 1.9% to 4.0%. As interest expenses drove profitability significantly lower during the past twelve months, the company expects to make a $100 million principal payment on its loan balances, effectively reducing the interest burden experienced during the period.

With positive EBITDA scheduled to fall between $520 million and $540 million, investors will see a swift recovery in the negative earnings per share balance. Considering these improvements, management has set expectations for payments to finish the year within $0.40 to $0.48 per share, representing a 17.6% to 41.2% increase from 2022 $0.34 earnings per share.

\Such an advance in earnings, an improving operational structure stemming from debt pay downs, and sustained revenue growth could all lead to analysts upping their price targets and investors assigning richer multiples for WOOF stock. 

Should you invest $1,000 in Chewy right now?

Before you consider Chewy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chewy wasn't on the list.

While Chewy currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Elon Musk's Next Move Cover

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Petco Health and Wellness (WOOF)
2.7305 of 5 stars
$8.73+2.5%N/A37.96Moderate Buy$11.54
Chewy (CHWY)
2.2057 of 5 stars
$36.80-2.8%N/A306.67Moderate Buy$42.65
Compare These Stocks  Add These Stocks to My Watchlist 

Gabriel Osorio-Mazilli

About Gabriel Osorio-Mazilli

Contributing Author: Value Stocks, Asian Markets, Macro Economics

Gabriel Osorio-Mazzilli has six years of experience in investing and trading financial markets and three years of institutional experience at both Goldman Sachs and Citigroup. He employs a bottom-top approach for picking value-driven investments and uses quantitative strategies in long/short equity trading.
Contact Gabriel Osorio-Mazilli via email at gosoriomazzilli@gmail.com.

Featured Articles and Offers

Search Headlines:

My Account -